exemestane,tamoxifen,triptorelin
azurity pharmaceuticals,astrazeneca,pfizer
['soft trial']
at #asco2023! don't miss the secondary analysis of the #soft trial evaluating pam50 intrinsic subtypes and risk of recurrence (ror) scores in premenopausal wmn with hr+ early-stage #bc presented by lauren brown! #bigagainstbc #ibcsg #eu4health 
Breast International Group - Facilitating and accelerating breast cancer research internationally